We found that, besides the well-established c-Myc, only BCL2L12 met both criteria in our phosphoproteome data (Figure 1C and Figure S4), suggesting that BCL2L12 might be a potential EYA1 substrate in glioma cells. Here, BCL2L12 is linked to central nervous system cancer.